Edit |   |
Antigenic Specificity | Esrp-2 |
Clone | 22C5.H7.A6 |
Host Species | Mouse |
Reactive Species | mouse |
Isotype | IgG2a kappa |
Format | IgG fraction |
Size | 25 µL |
Concentration | 1.0 mg/mL |
Applications | ELISA, Western Blot. This protein-A purified antibody has been tested for use western blotting and shows specific reactivity by with ESRP2 transfected cell lysates. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 77.4 kDa in size corresponding to Esrp-2 by western blotting in the appropriate cell lysate or extract. The antibody shows bands at ~77kD and 70kD and no reactivity is observed in cells transfected with GFP or ESRP1. A starting dilution of 1:1000 is suggested for western blotting. |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is an IgG fraction antibody purified from tissue culture supernatant by Protein-A chromatography followed by extensive dialysis against the buffer stated above. This antibody reacts with mouse Esrp-2 protein. A BLAST analysis was used to suggest cross-reactivity with Esrp-2 from mouse based on a 100% homology with the immunizing sequence. Cross-reactivity with Esrp-2 from other sources has not been determined |
Immunogen | Anti-Esrp-2 is produced by repeated immunizations of full length recombinant mouse Esrp-2 fusion protein. |
Other Names | mouse anti-Esrp2 antibody, mouse anti-Ersp-2 antibody, RNA-binding protein 35B, RNA-binding motif protein 35B |
Gene, Accession # | Esrp2, Gene ID: 77411, NCBI: NCBI, UniProt: Q8K0G8 |
Catalog # | 210-301-C32S |
Price | |
Order / More Info | Esrp-2 Antibody from ROCKLAND IMMUNOCHEMICALS INC. |
Product Specific References | Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, Guo W, Xing Y and Carstens RP (2010) An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. The EMBO Journal advance online publication 13 August 2010; doi:10.1038/emboj.2010.195 |